Agoracom Blog Home

Author Archive

MedX $MDX.ca Health to Present at the SNN Network Canada Virtual Event on Thursday, January 7, 2021 $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 3:42 PM on Thursday, December 31st, 2020
Home - MedX Health
  • Will be presenting at the SNN Network Canada Virtual Event on Thursday, January 7th at 5:00 PM EST.
  • Mike Druhan, President of Dermatology Products & Services, will host the presentation and answer investors’ questions.

MISSISSAUGA, ON / December 31, 2020 / MedX Health Corp. (TSXV:MDX)(“MedX” or “the Company“), a global leader in teledermatology, will be presenting at the SNN Network Canada Virtual Event on Thursday, January 7th at 5:00 PM EST. Mike Druhan, President of Dermatology Products & Services, will host the presentation and answer investors’ questions.

To access the live presentation, please use the following information:

SNN Network Canada Virtual Event 2021
Date: Thursday, January 7, 2021
Time: 5:00 PM Eastern Time (1:00 PM Pacific Time)
Webcast: https://www.webcaster4.com/Webcast/Page/2059/39362

Mr. Druhan will provide an overview of MedX’s unique image capture technology and its fully integrated telemedicine platform. MedX specializes in the Dermatology market. Included in the presentation will be MedX’s commercialization strategy and its SaaS financial model.

If you would like to book one-on-one investor meetings with MedX Health and to watch the MedX presentation, please make sure you are registered for the virtual event here: https://canada.snn.network/signup

One-on-one meetings will be scheduled and conducted via private, secure video conference through the conference event platform.

The SNN Network Canada Virtual Event website is available here: https://canada.snn.network/

For those unable to attend the live presentation, all company presentation “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”:

About MedX
MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also embedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain-free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union, Brazil and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain.

About SNN.Network
SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create your own watchlist and screen for ideas you’re interested in; find out about investor conferences you want to attend – all here on SNN.Network.

Contact:
Bill Mitoulas, Investor Relations
Phone: (416) 479-9547
Email: [email protected]

SOURCE: MedX Health Corp. via SNN Network

CLIENT FEATURE: Valeo Pharma $VPH.ca $VPHIF An Innovative Canadian Pharma Company With 9 Products Currently Marketed And 7 Products In Pipeline $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 1:56 PM on Thursday, December 31st, 2020

(VPH: CSE) (VPHIF: OTCQB) (VP2: FSE)

www.valeopharma.com

Why Valeo Pharma?

  • Commercial stage revenue generating Canadian pharmaceutical company
  • Approaching EBITDA positive in coming months
  • 9 products currently marketed ($40M. estimated peak sales / year)
  • 7 additional products in pipeline ($45M. estimated peak sales / year)
  • In-license business model, no development or clinical risk
  • $1.5M in quarterly revenue ending July 31, 2020
  • $5.26M in revenue for 9 months ending July 31, 2020

What Exactly Does Valeo Pharma Do?

  • Acquires Canadian rights to commercial stage, innovative and proprietary drugs
  • Commercializes innovative prescription products in Canada
  • Focused on Neurodegenerative Diseases,  Oncology and Hospital Specialty Products
  • Internally manages portfolio through all stages of commercialization

Watch Our Recent Interview:

Hub On AGORACOM / Corporate Profile

FULL DISCLOSURE: Valeo Pharma is an advertising client of AGORA Internet Relations Corp.

AGORACOM Small Cap 60: Famed Canadian Investor Sheldon Inwentash $IDK.ca $IDKFF Praises Loop Insights $MTRX $RACMF – MUST SEE

Posted by AGORACOM-JC at 1:06 PM on Thursday, December 31st, 2020
IDK-square-for-blog

Famed Canadian Investor Sheldon Inwentash Founder, Chairman and CEO ThreeD Capital praises Loop Insights. Inwentash is extremely impressed with the company’s technology and goes on to say that Loop Insights CEO Rob Anson is the hardest working small cap CEO he knows.

Hub On AGORACOM / Corporate Profile

#Platinum and #palladium to run higher as industrial demand picks up in 2021 – SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 9:53 AM on Thursday, December 31st, 2020

SPONSOR: New Age Metals Inc. The company owns one of North America’s largest primary platinum group metals deposits in Sudbury, Canada. The company has an updated NI 43-101 Mineral Resource Estimate of 2,867,000 PdEq Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces Inferred. Learn More.

  • Some analysts expect that as the global economy returns to some normalcy, palladium will resume its sharp uptrend from 2019.
  • Before the pandemic decimated the global economy, palladium prices were rocketing higher, hitting an all-time high above $2,700.
  • The price of the precious industrial metal has been driven by a significant supply and demand imbalance.
  • Demand for palladium has risen sharply over the years as automakers use more of the metal to meet tightening emission standards; meanwhile, supply has dropped sharply.

By: Neils Christensen

(Kitco News) – Although gold attracted a lot of attention in 2020, especially after hitting an all-time high in August, investors should have been paying attention to platinum group metals (PGMs), according to some analysts.

Like all other assets, the PGM space has been extremely volatile this past year as investors have tried to navigate the massive uncertainty and economic destruction caused by the COVID-19 pandemic. However, looking ahead, many analysts are fairly optimistic that platinum and palladium will attract new investor attention due to rising industrial demand as the global economy starts to recover from the effects of the coronavirus.

The two metals are primarily used in autocatalytic converters to reduce harmful exhaust emissions. Palladium is used in gasoline-powered engines, and platinum is used in diesel-powered vehicles. Platinum also has a slight advantage over palladium when it comes to physical demand as it also has a small jewelry market.

Some analysts expect that as the global economy returns to some normalcy, palladium will resume its sharp uptrend from 2019. Before the pandemic decimated the global economy, palladium prices were rocketing higher, hitting an all-time high above $2,700. The price of the precious industrial metal has been driven by a significant supply and demand imbalance. Demand for palladium has risen sharply over the years as automakers use more of the metal to meet tightening emission standards; meanwhile, supply has dropped sharply.

Platinum and palladium saw some renewed interest in November after Democratic candidate Joe Biden solidified his presidential win. Economists and market analysts expect that a Biden administration will lead to tighter environmental regulations and a renewed focus on developing green energy technology.

In a report published last month, Jonathan Butler, precious metals analyst at Mitsubishi, said that one of the first acts of the new government will bw to rejoin the Paris Climate Accord.

“Regardless of the ease with which the new administration can pass climate-friendly legislation from next year, rejoining the Paris agreement will be a clear signal of intent and will likely be followed by moves to improve vehicle fuel efficiency and regulate other pollutants as well as promote green energy. This is likely to be generally favorable to PGMs in emissions control, coming at a time when the auto industry is in recovery phase and as the rest of the United States follow California’s lead in addressing regulated pollutants and lowering average vehicle CO2 emissions,” he said.

While analysts expected platinum and palladium to push higher next year, the sentiment is mixed as to what metal will outperform in 2021. 

Analysts at Metals Focus said that they see palladium prices pushing to $3,000 an ounce in 2021. The analysts said that the metal is expected to see its 10th annual supply deficit next year.

“Even though global light-duty vehicle production will only return to its 2019 level by 2022, palladium autocatalyst offtake could touch a new all-time high in 2021,” the analysts said. “This reflects the metal’s dominance in the gasoline segment and the trend towards higher metal loadings in response to tightening emission standards.”

Metals Focus is relatively neutral on platinum as it expects prices to average $1,000 an ounce next year.

“Jewelry demand will remain healthy due to platinum’s hefty discount to gold. Overall, the market is expected to become broadly balanced in 2021, keeping above-ground stocks near record levels,” the analysts said.

Analysts at TD Securities are also slightly more optimistic on palladium compared to platinum. The Canadian bank also sees palladium pushing closer to $3,000 an ounce by the end of next year. The bank is an average price forecast of $2,656 an ounce for 2021.

Meanwhile, the TD analysts see platinum prices averaging the year around $1,013 an ounce, with prices peaking in the fourth quarter.

“Overall, the pandemic aftershock’s will likely result in a primary market surplus for platinum, particularly driven by a strong recovery in South African production, yet we expect investment demand for the metal to balance the market when the dust settles. While speculative demand for platinum has not benefited from the surge in appetite for gold and silver, it will likely benefit from speculative interest in the reflationary tailwinds expected for next year as the vaccine deployment helps the global recovery,” the commodity analysts said in their 2021 forecast report.

“At the same time, given that palladium will remain in a deficit, and that expectations for substantial headwinds from substitution may still not materialize as quickly as some anticipate, periods of scarcity and higher prices may still ensue in the New Year.”

However, not all analysts are convinced that palladium will be the biggest winner among PGMs in 2021.

Analysts at Commerzbank gives platinum a slight edge in 2021. In its outlook forecast, the bank sees platinum prices averaging $1,250 an ounce in the fourth quarter of next year, up nearly 17% from current prices. At the same time, palladium is seeing averaging the fourth quarter around $2,500 an ounce, up only 5% from current prices.

For the year, the German bank sees platinum prices averaging around $1,1125 an ounce; they see palladium averaging 2021 around $2475 an ounce.

One major wild card that could have a significant impact on PGM metals and push platinum demand higher is the development of green hydrogen technology.

While many economists are expecting to see surging demand for electric vehicles in the coming years, battery technology has not been sufficient enough for heavy-duty vehicles. Many companies are looking at hydrogen fuel cells to fill the important void.

Platinum is the critical metal used in the process that separates water into hydrogen and oxygen.

“New demand for platinum is definitely creating a compelling investment story for the precious metal and could drive industrial demand.” Said Steve Dunn, head of exchange-traded products at Aberdeen Standard Investments, in a recent interview with Kitco News. “This story can’t be found in palladium.”

Trevor Raymond, head of research at the World Platinum Investment Council, said that he is watching the developing green hydrogen economy very closely.

“For many governments fighting climate change has become a major priority, but fewer funds are available to make broad sweeping changes. The development of hydrogen as an alternative fuel source is one of the most cost-effective options we have,” he said in an interview with Kitco News.

“The COVID-19 pandemic gave the world a glimpse of what it could look like. There was clean air where there has never been clean air, and I don’t think we want to go back,” he added. “Green hydrogen gives you short-term cost-effectiveness and a long-term alternative energy solution.”

Not only is new demand from a growing sector increasing interest in platinum, but Dunn added that the precious metal could attract investor interest in 2021 as investors look for more value in the precious metal space.

Source: https://www.kitco.com/news/2020-12-31/Platinum-and-palladium-to-run-higher-as-industrial-demand-picks-up-in-2021.html

Innocan $INNO.ca Pharma Announces Closing of Private Placement $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 8:41 AM on Thursday, December 31st, 2020
Innocan-Blog
  • Announced that it has today closed a non-brokered private placement offering of 10,294,800 units of Innocan at a price of $0.23 per Units for aggregate gross proceeds of $2,367,804
  • All Common Shares and Warrants issued pursuant to the Offering will be subject to a four month statutory hold period commencing from the closing date under applicable securities laws.

Herzliya, Israel and Calgary, Alberta–(December 31, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan”) is pleased to announce that it has today closed a non-brokered private placement offering of 10,294,800 units of Innocan (the “Units”) at a price of $0.23 per Units for aggregate gross proceeds of $2,367,804 (the “Offering”).

All Common Shares and Warrants issued pursuant to the Offering will be subject to a four month statutory hold period commencing from the closing date under applicable securities laws.

Each Unit consists of one common share in the capital of the Company (“Common Share”) and one-half of one common share purchase warrant (“Warrant”). Each whole Warrant entitles the holder to purchase one Common Share at a price of $0.35 for a period of three years from the date of issuance.

Following the date of issuance of the Warrants, if the daily volume weighted average trading price of the Common Shares on the Canadian Securities Exchange for any period of 30 consecutive trading days equals or exceeds $0.70, the Company may, upon providing written notice to the holders of the Warrants (the “Acceleration Notice”), accelerate the expiry date of the Warrants to the date that is 30 days following the date of the Acceleration Notice.

Innocan intends to use the proceeds of the Offering for general working capital and corporate purposes.

“Our investors continue to show confidence in the Company. We are delighted to complete this private placement” stated Iris Bincovich, Chief Executive Officer of Innocan. “Despite the holiday season and the four months hold period that applies to the Units”.

About Innocan

The Company, through its wholly owned Israeli subsidiary, Innocan Pharma Ltd. (“Innocan Israel”), is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD“). Innocan Israel and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Coronavirus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. Innocan Israel plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. Innocan Israel is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

betterU $BTRU.ca Makes Significant Advances During 2020 $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 8:07 AM on Thursday, December 31st, 2020

OTTAWA, ON /  December 31, 2020 / betterU Education Corp. (TSXV:BTRU)(FSE:5OGA) (the “Company” or “betterU”) is pleased to provide an update on the development of the Company and the advances made over this last year. The following is a summary of the updates and agreements closed with individual press releases to follow in the new year.

Announced early 2020, betterU launched their beta version of their Enterprise SaaS Skills Development Platform called ‘Ready-To-Go’. While the Company was also impacted by the pandemic and many deals slowed in their development, betterU continued to push forward with Ready-To-Go and the beta clients with great success. The Company has advanced the platform from approximately 300 hosted courses in early 2020 to now over 3,700 courses across 200 categories. Combined with 800+ job role and 1,000+ subject based assessments, operating through a robust Learning Management System, betterU’s Ready-To-Go platform has gained a lot of interest around the world as the easiest all-in-one corporate solution for skills development and helping support job readiness.

While betterU’s beta program took a little longer to advance due to the slowdown in the market, the feedback from their clients provided valuable insight into finalizing a scalable, flexible, customizable, adaptable, multilingual solution that supports not only companies and governments, but also students, employees, underemployed and unemployed.

“I am so proud of the dedication and hard work of our team, board, advisors and partners that have worked closely with myself and betterU over this year to accomplish all that we have considering the circumstances. While there is still much work to do ahead of us, we now have proven solutions to achieve great results in 2021.” said Brad Loiselle, CEO betterU

In addition to the business update, the filing of the audited financial statements, MD&A and other related materials have been completed by the Company and DNTW and are in process to being made available on SEDAR. The delay in completion of the Audit was primary due to lack of responses from third-party confirmations with no material changes over last years audit. betterU is also currently working with their corporate legal team, Denton LLP and the Company’s Board of Directors to finalize the set-up of the Annual General Meeting (AGM) as well as working to ensure all disclosures are properly filed with TSXV and regulatory bodies to support trade resumption. The timelines and process are unknown at this time and the Company will provide updates after receiving notification from TSXV.

The following are the advancements that company has been making over 2020:

  • Unicaf and betterU execute strategic partnership and reseller agreement with plans to support thousands of students across Africa. Unicaf offers one of the most generous scholarship programmes available today having awarded so far over $100 million to more than 30,000 eligible applicants in 156 countries around the world. Full details of the partnership will be announced in January 2021.
  • NRCM and betterU execute strategic partnership and reseller agreement to support both business and the mass market of Morocco. NCRM, a subsidiary of MEDTECH Group, and 25 years focused on the technology industries include Banking, Retail and Governmental Operators. betterU and NRCM have already completely joint proposals for several government contracts and currently working on more. Full details of the partnership will be announced in January 2021.
  • Fuel Online and betterU execute strategic partnership and reseller agreement to support corporate skills development programs across 18 African countries. Fuel Online currently provides vocational training to over 200,000 people per week and the addition of betterU’s skills programs and platform will provide the next level of skills development programs. betterU will also be adding Fuel Online’s programs to their offering. Full details of the partnership will be announced in January 2021.
  • Paramount Staffing (USA) notified betterU on October 29th that they were selected as the only partner for skills development, with plans to develop a long-term partnership. In early 2020, Paramount Staffing, a $200+ Million people company and subsidiary of Proman, a $3 Billion staffing company headquartered in France, became one of betterU’s first beta customers for Ready-To-Go. Over the year, even during the constraints of the pandemic, betterU delivered top quality content, support and services. Paramount had been working with multiple learning providers that were inherited through their acquisitions over the years and decided after an extensive review that betterU was their partner of choice. Hear from their VP of Sales in this Video Testimonial. Full details of the opportunity will be announced in January 2021 as betterU and Paramount work to develop their combined 3-5 year plans.
  • betterU launched Skills Council of Canada (SSC) https://skillscouncil.ca/ to support a developing initiative to help upwards of 5,000 students across Canada to gain work experience and essential skills to be job ready. betterU’s brand SSC, will provide Work Integrated Learning (WIL) and skills development programs through betterU’s WIL+Skills platform with a core focus on Indigenous people and more vulnerable communities across Canada. betterU started their marketing and outreach campaigns October 2020 after receiving written approval from our collaborative partners. Outreach included connecting with Canadian educators, corporates, government, and Indigenous leaders, now with multiple partnership underway. Full details of this opportunity and associated partners will be announced in January 2021.
  • betterU’s beta skills program successful with Canada’s Positive Venture Group (PVG). betterU had curated multiple programs to be added to PVG’s branded platform which included over 200 learning paths focused on financial related jobs. PVG launched the first batch of courses for all employees which resulted with high reviews and success. Full details of the partnership growth will be announced in January 2021.
  • betterU launches their beta Reseller / Franchisee (Partners) program to support e-learning leaders looking to add Ready-To-Go to their own services or launch their own branded skills development platform, “powered by betterU”. The Partners model would enable those who already have a network of corporate partners or clients with the opportunity to support them in providing access to betterU’s thousands of courses, assessments, and a fully managed betterU service. betterU’s all-in-one skills platform has been developed to support scalability with a function that operates similar to a franchise. In order to grow betterU’s global reach, and network of sales partners, while ensuring betterU maintains control over the network, the Partners model is being tested. betterU is currently negotiating with possible Partners and full details of the partnership structure will be announced earlier 2021.
  • betterU established 100% owned operating entity, betterU Europe Ltd (“BEL”) in Dublin Ireland to help support developing opportunities for betterU across Africa and Europe.
  • betterU’s Corporate website is currently being updated with company advancements, programs, products and services. https://corporate.betteru.ca

betterU has many more growing opportunities in the pipeline including three completed RFPS for opportunities in the USA, Africa and Morocco. betterU has already been short listed for two of the RFPs and if successful will be announced. In addition, the Company has also received requests for additional strategic partnerships and resellers opportunities for organizations in Thailand, UAE and the USA.

The company has plans to increase their IR team to support more frequent public disclosures and business updates. Over this last year, betterU remained solely focused on the business to ensure the product pivot announced late 2019 was accomplishing the growth and validating the opportunity we expected would come.

“We were very pleased with the results achieved over this last year, despite the global challenges faced by many. Many companies local and abroad have been forced to close their doors, make pivots themselves to also overcome the challenges of this pandemic. betterU doubled down on our efforts to push forward for our shareholders and our vision. We thank all the people that have stayed supportive and we appreciate your patience. We are expecting great results and growth in 2021. Stay tuned!” said Brad Loiselle, CEO of betterU.

About betterU Education Corp.
betterU is an education-to-employment technology company offering an end-to-end solution leveraging business intelligence to automate skilling, reskilling, and upskilling for companies operating on domestic and global scales. The company supports all industries by providing them with everything an organization needs to launch and manage proper skills development programs, student work integrated learning and employee development, so that they can focus on what really matters: the growth of their people!

betterU’s Ready-To-Go platform provides access to a white labelled all-in-one skills platform that includes access to a library of 3,700 curated and developed skills courses, 800+ job role assessments, 1,000+ subject base assessments and a robust learning management system all hosted and supported by betterU. betterU also provides additional services to include a fully white labelled marketed program, in partnerships with betterU that includes a website that promotes the Company’s strategic partners Ready-To-Go program across their territory.

For more information, please visit https://corporate.betteru.ca

On behalf of the Board of Directors:
Brad Loiselle, CEO
1-(650) 267-8398
Email: [email protected]

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility

SOURCE: betterU Education Corp.

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 7:21 AM on Thursday, December 31st, 2020
kontrol-logo
  • Emerging Markets Consulting, LLC (EMC) has been retained to provide investor and public relations services.
  • EMC specializes in helping small and mid-sized public companies establish brand awareness and increase market share to its customer base while improving visibility to the institutional and retail investment community.

TORONTO, Dec. 31, 2020 — Kontrol Energy Corp. ( CSE:KNR ) OTCQB:KNRLF ) FSE:1K8 ) (” Kontrol ” or ” Company “), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that Emerging Markets Consulting, LLC (EMC) has been retained to provide investor and public relations services. EMC specializes in helping small and mid-sized public companies establish brand awareness and increase market share to its customer base while improving visibility to the institutional and retail investment community.

“With our anticipated stock exchange uplisting in 2021 and the recent launch of BioCloud, we believe this is an opportune time to share our story with a global investor audience,” says Paul Ghezzi, CEO of Kontrol.

James Painter, President of EMC, said, “We are pleased to represent Kontrol during the coming year. We have conducted our due diligence on the Company and have been very impressed with the management, share structure and overall business strategy.”

About Emerging Markets Consulting LLC

Based in Orlando, Florida, Emerging Markets Consulting, LLC (EMC) brings over 40 years combined experience in the investor relations industry. EMC is an international investor relations firm with affiliates around the world. EMC is relationship-driven and results-oriented with the goal of seeking attractive emerging companies and concentrating its resources and efforts to serve a limited number of high-quality clients. For more information, visit EMC’s website at www.emergingmarketsllc.com

About Kontrol BioCloud TM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

https://www.facebook.com/kontrolenergy
https://twitter.com/kontrolenergy
https://www.linkedin.com/company/kontrol-energy-corp

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Emerging Markets Consulting, LLC
James S. Painter, CEO
390 North Orange Ave Suite 2300
Orlando, Florida 32801
E-mail: [email protected] Web: www.emergingmarketsllc.com

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Receives $750,000 Emission Order Including BioCloud Sales and Initial BioCloud Order from Ontario Electricity Generator $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 11:48 AM on Wednesday, December 23rd, 2020
kontrol-logo
  • Announced a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario’s largest Electricity Generators
  • The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021

TORONTO, ON / December 23, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario’s largest Electricity Generators. The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021.

“We are very pleased to receive a significant order in our core business with a US manufacturing customer which also includes 2 BioCloud units as part of a package sale,” says Paul Ghezzi, CEO of Kontrol. “Our corporate strategy is to quote BioCloud units as part of all new sales opportunities from our core business. In addition, we are pleased that one of Ontario’s largest Electricity Generators has ordered an initial 2 units of BioCloud. Both customers have additional scale potential with numerous facilities. Our recent product launch and technology walk-through in December was a success and has initiated accelerating interest in how BioCloud can help create safer spaces.”

Distribution Orders

To date the Company has received 40 initial distribution orders for delivery in January from its existing distribution network. The Company has entered into 6 distribution agreements (1 exclusive and 5 non-exclusive) and is in negotiations for various potential additional non-exclusive distributions agreements. Distribution is a key part of our go to market strategy that can allow the Company to scale quickly.

“In a short period of time since the official launch of BioCloud in December we have received strong interest and numerous distribution requests,” says Gary Saunders, VP Kontrol. “We envision many more agreements across the globe as we focus on growing the BioCloud business.”

As the Company continues to build its distribution business, we anticipate that distributors will be required to maintain a minimum of 250-unit sales per annum to retain non-exclusivity and distributor pricing. The Company’s internal goal is to have 30 regional distributors established by the end of Q1 2021.

Customer Pilots

The Company plans to begin numerous pilots with both existing customers of Kontrol and new potential customers. The purpose of the pilots is to provide potential customers with various specific application use cases across their facilities. The types of pilot customers will include the sectors of commercial real-estate, grocery stores, franchised restaurants, educational facilities and other. Subject to pilot customer approval Kontrol may announce customer pilots or may operate them under non-disclosure agreement.

Recurring Revenue

The BioCloud unit operates with a proprietary detection chamber. The retail price for the detection chamber consumable will range from $400 to $500 and the recommended replacement is three times per year or whenever the detection chamber comes into contact with SARS-CoV-2. Customers that purchase multiple units will receive volume discounts for the detection chamber.

Re-Agent Supply Chain

The detection chamber includes a specific re-agent system. To date the Company has been sourcing its re-agents from the United States. The Company has initiated discussions and testing to source its re-agents from Canadian based sources. By doing so it is seeking to add more of its supply chain in Canada but also reduce the costs of the detection chamber. Further updates will be provided following additional testing.

Essential Service

Kontrol and its manufacturing supply chain operate as an Essential Service provider and do not anticipate being impacted by applicable COVID-19 shutdowns.

About Kontrol BioCloudTM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

$KABN.ca North America Announces Closing of $1.15 Million Brokered Private Placement Financing $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 11:34 AM on Wednesday, December 23rd, 2020
kabn-square-new
  • Announced that it has closed its previously announced brokered private placement of units of the Company, pursuant to which the Company issued 7,666,667 Units at a price of $0.15 per Unit for aggregate gross proceeds of $1,150,000
  • The Offering was led by Mackie Research Capital Corporation as sole agent and sole bookrunner

TORONTO, ON / December 23, 2020 / KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America” or “KABN NA“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has closed its previously announced brokered private placement of units of the Company (the “Units“), pursuant to which the Company issued 7,666,667 Units at a price of $0.15 per Unit (the “Offering Price“) for aggregate gross proceeds of $1,150,000 (the “Offering“). The Offering was led by Mackie Research Capital Corporation as sole agent and sole bookrunner (the “Agent“).

Each Unit is comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant is exercisable to acquire one Common Share (a “Warrant Share“) at an exercise price of $0.20 per Warrant Share, for a period of 24 months from the closing of the Offering.

The Company intends to use the net proceeds raised under the Offering for working capital and general corporate purposes.

In connection with the Offering, the Agent received an aggregate cash fee equal to 8.0% of the gross proceeds from the Offering including in respect of any exercise of the Agent’s Option. In addition, on closing the Company granted the Agent non-transferable compensation options (the “Compensation Options“) equal to 8.0% of the total number of Units sold under the Offering (including in respect of any exercise of the Agent’s Option). Each Compensation Option entitles the holder thereof to purchase one Unit at an exercise price equal to the Offering Price for a period of 24 months following the Closing.

In addition, the Company has paid the Agent a financial advisory fee satisfied by the issuance of 830,000 Common Shares.

The securities issued pursuant to the Offering are subject to a four-month and one day hold period under applicable securities laws in Canada.

The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.

About KABN North America

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN NA’s propriety technology suite includes 4 key products:

Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their Self Sovereign Identity and to use Liquid Avatars to share verifiable credentials, including access, identity and designation credentials, and public and permission based private data when they want and with whom they want. www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com

KABN KASH is a cashback, loyalty and engagement program that powers the KABN NA’s revenue ecosystem. KABN NA provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

KABN Systems NA Holding Corp. is a publicly listed company listed on the Canadian Securities Exchange under the symbol “KABN”.

For further information, please contact:

David Lucatch
647-725-7742 Ext. 701
[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the proposed use of the net proceeds of the Offering.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

SOURCE: KABN Systems NA Holdings Corp.

CLIENT FEATURE: Universal #PropTech $UPI.ca Delivering Healthy Building Solutions and Services For Building Developers, Owners and Operators #AI #IoT $SNE $MSFT $HON

Posted by AGORACOM-JC at 9:43 AM on Wednesday, December 23rd, 2020

UPI: TSX-V

www.universalproptech.com

As the name implies “PropTech” is a combination of two words and stands for “property technology.”  As simple as that is, the implementation and importance of PropTech is anything but. 

Like every other industry on the planet that is incorporating technology to create greater efficiencies and experiences, the commercial real estate market is no different and is seeing the rapid adoption of;

  • Artificial Intelligence
  • Machine learning
  • Big data
  • Internet of Things (IoT Sensors)
  • Cloud computing

To create cost savings by reducing and even eliminating existing costs, create greater efficiencies for the operation and maintenance of real estate assets, as well as, improve the design of new builds.

IMPACT OF COVID-19

The COVID-19 pandemic has served to significantly increased the demand for PropTech in the commercial real estate market as follows:

  • The need for solutions to get workers back into workplace buildings and offices. Specifically, the need to identify bacteria and viruses in indoor air quality, as well as, the ability to sanitize immediately and effectively.
  • The need to create even greater cost savings and efficiencies for real estate owners that will continue suffering losses until workers significantly return to the workplace.

WHY UNIVERSAL PROPTECH (UPI:TSXV)?

Whereas many companies are just now trying to capitalize on the opportunities presented in the current and massive future of PropTech, Universal PropTech Inc. (“UPI”) a diversified investment platform delivering healthy building solutions and services for building developers, owners and operators in Canada.  More than just lip service, UPI has been successfully delivering its PropTech solutions for years, with revenues over the last 3 years as follows:

2017 – $13.8M

2018 – $13.7M

2019 – $15.9M

Headquartered in Toronto, UPI has offices across Canada including Halifax,Montreal, and Ottawa. 

COMPANY HIGHLIGHTS

  • Used in Federal Government facilities for over 40 years
  • Provides real estate managers turnkey HVAC Building Controls design, equipment, installation and ongoing operations and maintenance services for Industrial, Commercial, Institutional and Multi-residential customers
  • Already possesses under-utilized IP in building controls to add in additional monitoring inputs and equipment controls
  • Diverse revenue streams via products, installations and ongoing
  • Key strategic partnerships afford the ability to monitor real-time utility meters, key BAS and systems data in a building.
  • Team has the capability to make sense of this data and apply advanced web tools to make recommendations to fine tune a building, saving from 5% to 15% of a facilities energy spend without capital expenditure
  • VCI offers the depth and breadth of Building Automation Systems (BAS) knowledge and products from the likes of Siemens and Honeywell to support building automation systems

RECENT NEWS

COVID-19 STRATEGY

As businesses return to the office, property managers must think about the design and safety of their buildings for occupants. Traditional cleaning methods are ineffective at preventing transmission. UV technology is able to sanitize all surfaces free from pathogens. UPI is capitalizing on this opportunity by building and acquiring UV technology as it is the best in the market to administer and integrate it into healthy buildings in Canada.

FIND OUT MORE:

Hub On AGORACOM / Corporate Profile